Athanase Innovation AB (ATIN) — Cash Flow Reinvestment Rate

Latest as of June 2024: 0.99x

Athanase Innovation AB (ATIN) has a Cash Flow Reinvestment Rate of 0.99x as of June 2024, reinvesting Skr6.49 Million (capex Skr6.49 Million ) from operating cash flow of Skr6.54 Million. Explore ATIN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.99x
(Capex + Investments) / Operating CF

Total Reinvested

Skr6.49 Million
Capex + Investments

Operating Cash Flow

Skr6.54 Million
SEK

Capital Expenditures

Skr6.49 Million
SEK

Athanase Innovation AB Cash Flow Reinvestment Rate (2018–2021)

Historical reinvestment intensity for Athanase Innovation AB across 4 annual periods. Also explore ATIN current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Athanase Innovation AB (2018–2021)

Year-by-year capital reinvestment analysis for Athanase Innovation AB. For live market cap and broader valuation context, see ATIN company net worth.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2021 9.19x Skr212.40 Million Skr23.10 Million Skr65.00K
2020 0.00x Skr0.00 Skr22.34 Million Skr0.00
2019 0.00x Skr0.00 Skr28.38 Million Skr0.00
2018 0.00x Skr0.00 Skr15.05 Million Skr0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow